Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Mohamed E. Abdelsalam Image

      Mohamed E. Abdelsalam, M.D.

      Department of Interventional Radiology, Division of Diagnostic Imaging

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2003Cairo University Faculty of Medicine, Cairo, EG, Doctorate of Medicine, MBBS

      Postgraduate Training

      2013-2016Clinical Fellowship, Vascular, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2005-2008Clinical Residency, Cairo University Faculty of Medicine, Cairo
      2004-2005Clinical Internship, Cairo University Faculty of Medicine, Cairo

      Licenses & Certifications

      2022DEA - Woodlands
      2021American Board of Radiology, Diagnostic and Interventional Radiology
      2019DEA - West Houston
      2019DEA - Holcombe
      2016Texas Medical Board

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2023

      Other Professional Positions

      Visiting Scientist, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2013

      Assistant Lecturer, National Cancer Institute, Cairo University, Cairo, 2009 - 2011

      Chief Senior Registrar, Nile Diagnostic Center, Cairo, 2009 - 2010

      Assistant Medical Director, National Cancer Institute, Cairo University, Cairo, 2009 - 2010

      Assistant Lecturer, National Cancer Institute, Cairo University, Cairo, 2009 - 2009

      Diagnostic Imaging Specialist, Nile Diagnostic Center, Cairo, 2008 - 2010

      Chief Resident, National Cancer Institute, Cairo University, Cairo, 2007 - 2008

      Extramural Institutional Committee Activities

      Chairman, Journal Club, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Chairman, Interventional Radiology Continuing Education (I.C.E.) Program, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2022

      Member, Institutional Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016

      Member, Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Honors & Awards

      2020Teaching IR Physician of the Year Award - IR Department 2020, The University of Texas MD Anderson Cancer Center
      2016Spotlighted Publication, The University of Texas MD Anderson Cancer
      2013Distinguished Abstract Award, Society of Interventional Radiology
      20121st Place Scientific Exhibit, Global Embolization Symposium Technologies (GEST)
      2010Assistant Lecturer of the Year Award, Cairo University Faculty Society
      2010Certificate Of Appreciation, Radiology Department, National Cancer Institute Cairo University
      2003Excellent with High Honors MBBCh, Cairo University Faculty of Medicine

      Professional Memberships

      Cardiovascular and Interventional Radiological Society of Europe

      2026 - Present

      American Urological Association

      2018 - Present

      American Medical Association

      2017 - Present

      Harris County Medical Society

      2016 - Present

      Society of Interventional Radiology

      2010 - Present

      Radiologic Society of North America

      2010 - Present

      Egyptian Society of Radiologist

      2010 - Present

      Egyptian Syndicate of Physicians

      2008 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2025. Ablative Techniques for Non-Operable Small Renal Masses. Invited. 3rd Annual UT Christopher G. Wood Advances In Urologic Oncology Symposium. Austin, TX, US.
      2. 2024. Salvage Therapies for Recurrence: Ablation. Invited. 2nd Annual UT Christopher G. Wood Advances in Urologic Oncology Symposium. Austin, TX, US.
      3. 2023. Thermal ablation of T1a renal tumors. Conference. UT Christopher G. Wood Advances in Urologic Oncology Symposium. Austin, TX, US.
      4. 2023. Ablation. Invited. UT Christopher G. Wood Advances in Urologic Oncology Symposium. Austin, TX, US.
      5. 2020. Introduction to Interventional oncology: Concepts and application. Invited. The University of Texas Medical Branch. Galveston, Texas, US.

      National Presentations

      1. 2026. Ablation as curative option - Does the device matter?. Invited. GEST 2026 Annual Meeting. New York, NY, US.
      2. 2026. Current Data and Future Direction of Combination Therapy: TACE + Systemic Therapy. Invited. GEST 2026 Annual Meeting. New York, NY, US.
      3. 2026. Tricky RCC ablations: How I do it and why ?. Invited. GEST Online Educational Series- Expanding the frontier of Cryoablation Therapy.
      4. 2025. Renal Ablation: From Pre-procedural Evaluation Through Post-procedural Care. Invited. SIR 2025 Annual Scientific Meeting. Nashville, TN, US.
      5. 2025. Factors Influencing Ablation Technology Selection in Percutaneous Renal Ablation. Invited. SIR 2025 Annual Scientific Meeting. Nashville, TN, US.
      6. 2023. Effectiveness of Radiofrequency ablation for Biopsy proven T1a renal cell carcinoma (RCC)m greater than or equal to 3 cm. Invited. Proceedings of the Society of Interventional Radiology 2023 Annual Scientific Meeting. Phoenix, AZ, US.
      7. 2023. Radiofrequency ablation provides excellent results for ablation of T1a renal tumors. Invited. Proceedings of the Society of Interventional Radiology 2023 Annual Scientific Meeting. Phoenix, AZ.
      8. 2022. Long-term survival outcome radiofrequency ablation of biopsy proven T1a renal cell carcinoma (RCC). Conference. CIRSE 2022 Annual Scientific Meeting. Barcelona, ES.
      9. 2022. Renal Ablation: When and How?. Invited. Academy of Online Radiology Education (ACORE), US.
      10. 2020. Hepatocellular Carcinoma: Multidisciplinary Approach. Conference. ACORE Online Educational Series, US.
      11. 2020. Introduction to Interventional Radiology: Concepts and Applications. Conference. ACORE Online Educational Series, US.
      12. 2020. Efficacy of Percutaneous Image-Guided Thermal Ablation for Renal Cell Carcinoma Following Ipsilateral Partial Nephrectomy. Conference. Proceedings of the 45th Annual Meeting of the Society of Interventional Radiology - ONLINE MEETING, US.
      13. 2019. Oncologic Effectiveness of Image-Guided Thermal Ablation for Recurrent Renal Cell Carcinoma (RCC) after Ipsilateral Partial Nephrectomy: Tertiary Cancer Center Experience. Conference. Proceedings of the 2019 Meeting of the American Urological Association. Chicago, IL, US.
      14. 2019. Radiofrequency Ablation of Pathologically-Proven T1a Renal Tumors: 16 Years' Experience. Conference. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology. Austin, TX, US.
      15. 2019. Magnetic Resonance Image-Guided Renal Biopsy: Tertiary Cancer Center Experience. Conference. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology. Austin, TX, US.
      16. 2018. Long-term follow-up of image guided thermal ablation for Pathologically proven T1a Renal tumors: Radiofrequency ablation or cryoablation. Conference. Proceedings of the 43rd Annual Meeting of the Society of Interventional Radiology. Los Angeles, CA, US.
      17. 2017. Image guided thermal ablation for pathologically proven T1a renal cell carcinoma in the setting of other non-renal primary cancer: A Tertiary Cancer Center Experience. Conference. Proceedings of the 42nd Annual Meeting of the Society of Interventional Radiology. Washington, DC, US.
      18. 2014. Balloon-assisted Flow Diversion and Catheterization for Hepatic Bland Embolization (On-line Presentation). Conference. WCIO, US.
      19. 2013. Portal & Hepatic Veins Embolization Prior to Hepatectomy (On-line Presentation). Conference. WCIO, US.
      20. 2013. CT findings after irreversible electroporation ablation in a porcine model: Radiologic-pathologic correlation. Conference. Proceedings of the 38th Annual Meeting of the Society of Interventional Radiology. New Orleans, LA, US.
      21. 2013. Irreversible electroporation (IRE) in cirrhotic liver: Preliminary experience in a large animal model. Conference. Proceedings of the 38th Annual Meeting of the Society of Interventional Radiology. New Orleans, LA, US.
      22. 2013. Irreversible electroporation (IRE) ablation of the lumbar vertebrae in a porcine model: A correlation of clinical, radiologic and pathologic findings. Conference. Proceedings of the 38th Annual Meeting of the Society of Interventional Radiology. New Orleans, LA, US.
      23. 2012. Impact on C-arm cone beam CT on subselective catheterization in patients undergoing chemoembolization for hepatocellular carcinoma. Conference. Proceedings of the 37th Annual Meeting of the Society of Interventional Radiology. San Francisco, CA, US.

      International Presentations

      1. 2026. Minimally Invasive, maximally effective: Renal Ablation From A-Z. Invited. NLICC 2026 Annual scientific meeting. Cairo, EG.
      2. 2025. Renal Ablation: Tips and Tricks in Technique. Invited. SAFIRE-SMRI Annual Meeting. Casablanca, MA.
      3. 2025. How to Master Renal Ablation. Invited. SAFIRE-SMRI Annual Meeting. Casablanca, MA.
      4. 2024. Heat, Freeze, Treat: Mastering Renal Ablation Techniques. Invited. Annual Congress of the National Cancer Institute: Bridging Gaps in Oncology. Cairo, EG.
      5. 2023. Fundamentals of Interventional Radiology, Part 2. Conference. The Scientific Council of Egyptian Fellowship of Radiology for Interventional Radiology Residents (ONLINE), EG.
      6. 2023. Fundamentals of Interventional Radiology, Part 1. Conference. The Scientific Council of Egyptian Fellowship of Radiology for Interventional Radiology Residents (ONLINE), EG.
      7. 2022. Y90 for HCC: Who gets treatment? Part 2. Invited. The Moroccan Society of Interventional Radiology (MSIR) and the African Society of Interventional Radiology and Endovascular Therapy (SAFIRE) Virtual Session. Virtual Session, US.
      8. 2022. Y90 for HCC: Who gets treatment? Part 1. Invited. The Moroccan Society of Interventional Radiology (MSIR) and the African Society of Interventional Radiology and Endovascular Therapy (SAFIRE) Virtual Session. Virtual Session, US.
      9. 2022. Renal Ablation: Where we stand?. Invited. The Moroccan Society of Interventional Radiology (MSIR) and the African Society of Interventional Radiology and Endovascular Therapy (SAFIRE) Virtual Session. Virtual Session, US.
      10. 2022. Radioembolization for HCC: Who is candidate?. Invited. 7th International Conference on Radiation Medicine (ICRM 2022) Virtual Meeting 2022. Riyadh, SA.
      11. 2022. Renal Ablation: Tertiary Cancer Center Experience. Invited. 7th International Conference on Radiation Medicine (ICRM 2022) Virtual Meeting 2022. Riyadh, SA.
      12. 2022. Radioembolization: An Update on Dosimetry?. Invited. 7th International Conference on Radiation Medicine (ICRM 2022) Virtual Meeting 2022. Riyadh, SA.
      13. 2021. Renal Ablation Update. Invited. Pan Arab Interventional Radiology Society (PAIRS) Virtual Meeting 2021, AE.
      14. 2019. Percutaneous Renal Masses Cryo-Ablations vs. RFA: When and How?. Invited. Middle East Endovascular Therapy Symposia. Cairo, EG.
      15. 2018. Renal Ablation: When, Who, and Why?. Invited. Annual Congress of the National Cancer Institute: Bridging Gaps in Oncology. Cairo, EG.
      16. 2018. Renal Ablation: How we do it?. Invited. Annual Congress of the National Cancer Institute: Bridging Gaps in Oncology. Cairo, EG.
      17. 2018. Outcomes of Renal Ablation. Invited. Annual Congress of the National Cancer Institute: Bridging Gaps in Oncology. Cairo, EG.
      18. 2018. Radiofrequency ablation of pathologically proven T1a renal tumors: 15 years follow up; A tertiary cancer center experience. Conference. ASCO 2018 Annual Meeting. Chicago, US.
      19. 2016. Incidental renal tumors in cancer survivors: Minimally invasive management by image guided thermal ablatio. Conference. ASCO 2016 Cancer Survivorship Symposium. Chicago, US.
      20. 2012. Irreversible electroporation (IRE) ablation of the lumbar vertebrae in a porcine model. Conference. SIO 4th Annual World Conference of Interventional Oncology. Chicago, US.
      21. 2010. Ostoid osteoma: what every Radiologist should know. Conference. National Cancer Institute. Cairo, EG.
      22. 2010. D.D. of renal cystic mass. Conference. NCI Monthly Meeting. Cairo, EG.
      23. 2009. New MRI techniques in evaluation of pancreatic tumors. Conference. National Cancer Institute. Cairo, EG.
      24. 2009. MRI made easy. Conference. National Cancer Institute. Cairo, EG.
      25. 2008. Basic principles of MRI physics. Invited. Cairo, EG.
      26. 2008. CT thoracic imaging: indications, technique & normal findings. Invited. National Cancer Institute. Cairo, EG.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Kouzi ZE, Kouzy R, Aziz A, Rooney MK, Lee SR, McRae SE, Shah KY, Abdelsalam ME, Lin EY, Hassanzadeh C, Choi S, Nguyen Q, Frank SJ, Shelan M, Mayo LL, McGuire S, Yevich S, Mohamad O. Hyaluronic Acid Rectal Wall Infiltration and Reversal in Patients With Prostate Cancer Undergoing Radiation Therapy–A Case Series. Advances in Radiation Oncology 11(11):102119, 2026. e-Pub 2026.
      2. El Kouzi, Z, Kouzy, R, Aziz, A, Rooney, M, Lee, S, McRae, SE, Shah, KY, Abdelsalam, ME, Lin, EY, Hassanzadeh, CJ, Choi, S, Nguyen, Q, Frank, SJ, Shelan, M, Mayo, LL, McGuire, SE, Yevich, SM, Mohamad, O. Hyaluronic Acid Rectal Wall Infiltration and Reversal in Patients With Prostate Cancer Undergoing Radiation Therapy–A Case Series. Advances in Radiation Oncology 11(11), 2026. e-Pub 2026. PMID: 42571382.
      3. Marey A, Elkeden H, Alrohaibani Y, Khalaf M, Karam JA, Matin S, Habibiollahi P, Odisio BC, Ahrar K, Abdelsalam ME. Percutaneous ablation of T1b renal tumors: a review. Cancer Imaging 26(1), 2026. e-Pub 2026. PMID: 41998698.
      4. Abdelsalam ME, Patel MN, Murray RD, Aziz SK, Shields H, Chien P, Yevich S, Metwalli ZA, Wang Z, Lin JS, Huang SY, Irwin D, Lu T, Lee SR, Abudayyeh A, Habibollahi P, Odisio BC, Ahrar K, Gupta S. Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience. Curr Oncol 33(4), 2026. e-Pub 2026. PMID: 42041711.
      5. Khavandi MM, Agahi KN, Lee SS, Kaseb AO, Odisio BC, Abdelsalam ME, Kuban JD, Sheth RA, Avritscher R, Kappadath SC, Mahvash A, Habibollahi P. Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience. J Hepatocell Carcinoma 13:546213, 2026. e-Pub 2026. PMID: 41929283.
      6. Abdelsalam ME, Awad A, Kang F, Wang Z, Irwin D, Habibollahi P, Odisio BC, Lu T, Metwalli ZA, Lee SR, Karam JA, Matin SF, Ahrar K. Percutaneous Cryoablation of Clinical T1b Renal Tumors: A Tertiary Cancer Center Experience. Cardiovasc Intervent Radiol, 2026. e-Pub 2026. PMID: 41845108.
      7. Kamp WM, Xiong MX, Khavandi M, Sheth R, Abdelsalam M, Nezami N, Tam A, Huang S, Habibollahi P. Safety and Effectiveness of Adrenal Cryoablation for Patients with Melanoma Metastases on Concurrent Targeted Therapy or Immunotherapy. JVIR 37(3):107850, 2026. e-Pub 2026. PMID: 40976553.
      8. Khavandi, MM, Agahi, KN, Lee, SS, Kaseb, A, Odisio, BC, Abdelsalam, ME, Kuban, JD, Sheth, RA, Avritscher, R, Kappadath, SC, Mahvash, A, Habibollahi, P. Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 13, 2026. e-Pub 2026. PMID: 41929283.
      9. Abdelsalam ME, Ahrar K, Sheth RA, Shah KY, Yevich S, Gurusamy V, Odisio BC, Tam AL, Mahvash A, Habibollahi P. Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors. CA Cancer J Clin 76(1):e70051, 2026. e-Pub 2026. PMID: 41368901.
      10. Khavandi MM, Nezami N, Huang S, Tam AL, Abdelsalam ME, Shah KY, Patel M, Odisio BC, Mahvash A, Kuban JD, Sheth RA, Habibollahi P. Outcomes of transjugular intrahepatic portosystemic shunt creation for the management of portal hypertension complications in cancer patients. Abdom Radiol (NY) 50(12):6161-6171, 2025. e-Pub 2025. PMID: 40434426.
      11. Awad, AA, Ahrar, K, Stafford, J, Abdelsalam, ME. MR Imaging-Guided Cryoablation of Small Renal Masses. Magnetic resonance imaging clinics of North America 33(4):735-741, 2025. e-Pub 2025.
      12. Mahdi Khavandi M, Pourhassan S, Pal K, Shah K, Patel M, Gurusamy V, Nezami N, Abdelsalam ME, Odisio BC, Kuban JD, Sheth RA, Habibollahi P. Technical Effectiveness and Clinical Outcomes of Mechanical Thrombectomy in Cancer Patients Presenting with IVC Filter-Associated Deep Venous Thrombosis: A Retrospective Study. Ann Vasc Surg 119:169-179, 2025. e-Pub 2025. PMID: 40553836.
      13. Awad A, Ahrar J, Abdelsalam ME. Cystoscope assisted trans-conduit removal of fragmented percutaneous nephrostomy catheter. Urol Case Rep 62, 2025. e-Pub 2025. PMID: 40919173.
      14. Awad A, Ahrar K, Stafford J, Abdelsalam ME. MR Imaging-Guided Cryoablation of Small Renal Masses. Magnetic Resonance Imaging Clinics of North America, 2025.
      15. Abdelsalam ME, Awad A, Bassett RL, Lu T, Irwin D, Shah KY, Odisio BC, Habibollahi P, Karam JA, Matin SF, Ahrar K. Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell Carcinoma. Biomedicines 13(6), 2025. e-Pub 2025. PMID: 40564015.
      16. Singer ED, Karbasian N, Katz DS, Wong VK, Abdelsalam ME, Stanietzky N, Nguyen TT, Shenoy-Bhangle AS, Badawy M, Revzin MV, Shehata MA, Eltaher M, Elsayes KM, Korivi BR. Renal bleeding: imaging and interventions in patients with tumors. Diagn Interv Radiol 31(3):161-170, 2025. e-Pub 2025. PMID: 38874163.
      17. Haddad A, Khavandi MM, Lendoire M, Belkacem A, Chiang YJ, Gupta S, Tam A, Odisio BC, Mahvash A, Abdelsalam ME, Lin E, Kuban J, Newhook TE, Tran Cao HS, Tzeng CD, Huang SY, Vauthey JN, Habibollahi P. ASO Visual Abstract: Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-risk Factors for Inadequate Regeneration. Ann Surg Oncol 32(4):2495-2496, 2025. e-Pub 2025. PMID: 39838241.
      18. Haddad A, Khavandi MM, Lendoire M, Acidi B, Chiang YJ, Gupta S, Tam A, Odisio BC, Mahvash A, Abdelsalam ME, Lin E, Kuban J, Newhook TE, Tran Cao HS, Tzeng CD, Huang SY, Vauthey JN, Habibollahi P. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol 32(3):1752-1761, 2025. e-Pub 2025. PMID: 39633174.
      19. Lin YM, Paolucci I, Albuquerque Marques Silva J, O'Connor CS, Hong J, Shah KY, Abdelsalam ME, Habibollahi P, Jones KA, Brock KK, Odisio BC. Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study. Eur Radiol 34(9):5541-5550, 2024. e-Pub 2024. PMID: 38334762.
      20. Abdelsalam ME, Lu T, Baiomy A, Awad A, Odisio BC, Habibollahi P, Irwin D, Karam JA, Matin SF, Stafford J, Ahrar K. Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol 34(9):5551-5560, 2024. e-Pub 2024. PMID: 38400904.
      21. Abdelsalam ME, Mecci N, Awad A, Bassett RL, Odisio BC, Habibollahi P, Lu T, Irwin D, Karam JA, Matin SF, Ahrar K. Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. Cancers (Basel) 16(10), 2024. e-Pub 2024. PMID: 38791894.
      22. Abdelsalam ME, Hudspeth TN, Leonards L, Kusin SB, Buckley JR, Bassett R, Awad A, Karam JA, Matin SF, Lu T, Ahrar K. Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. Eur Urol Open Sci 57:45-50, 2023. e-Pub 2023. PMID: 38020520.
      23. Abdelsalam ME, Awad A, Baiomy A, Irwin D, Karam JA, Matin SF, Sheth RA, Habibollahi P, Odisio BC, Lu T, Ahrar K. Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765867.
      24. Habibollahi P, Odisio BC, Gurusamy V, Kuban JD, Avritscher R, Abdelsalam ME, Chasen BA, Murthy R, Mahvash A. Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration. Curr Oncol 29(12):9582-9592, 2022. e-Pub 2022. PMID: 36547167.
      25. Agahi KN, Mahvash A, Abdelsalam ME. Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience. Curr Oncol 29(10):7051-7058, 2022. e-Pub 2022. PMID: 36290830.
      26. Donato F, Ahrar K, Karam J, Matin S, Abdelsalam ME, Sabir S. Combined transarterial embolization and percutaneous image-guided ablation for the treatment of T1B and central renal tumors in patients with high surgical risk. Am J Interv Radiol(6:11), 2022. e-Pub 2022.
      27. Wang MX, Guccione J, Korivi BR, Abdelsalam ME, Klimkowski SP, Soliman M, Shalaby AS, Elsayes KM. Gastrointestinal bleeding: imaging and interventions in cancer patients. Br J Radiol 95(1135):20211158, 2022. e-Pub 2022. PMID: 35451853.
      28. Hosseini Shabanan S, Nezami N, Abdelsalam ME, Sheth RA, Odisio BC, Mahvash A, Habibollahi P. Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy. Curr Oncol 29(6):3825-3848, 2022. e-Pub 2022. PMID: 35735415.
      29. Kamel S, Wang MX, Ghannam S, Gopal A, Baqai F, Rohren S, Patel P, Khan Z, Aly M, Reiter AM, Zook S, Udayakumar N, Kumaraval M, Kamaya A, Jambhekar K, Elsamaloty H, Gaballah A, Stein L, Abdelsalam M, Chernyak V, Elsayes KM. Acing the fundamentals of radiology: An Online Series for Medical Students and Interns. J Comput Assist Tomogr 46(4):46(4):614-620, 2022. e-Pub 2022. PMID: 35405708.
      30. Abdelsalam ME, Figueira TMA, Ensor J, Tam AL, Avritscher R, Kaseb A, Gupta S. The Impact of the Use of C-Arm Cone-Beam CT During Chemoembolization for Hepatocellular Carcinoma. Curr Med Imaging 18(4):372-380, 2022. e-Pub 2022. PMID: 34420509.
      31. Teyateeti A, Mahvash A, Long J, Abdelsalam M, Avritscher R, Kaseb A, Odisio B, Ravizzini G, Surasi D, Teyateeti A, Macapinlac H, Kappadath SC. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol 27(47):8166-8181, 2021. e-Pub 2021. PMID: 35068861.
      32. Abdelsalam ME, Sabir SH, Ba SBK, Karam JA, Matin SF, Wood CG, Ahrar K. Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies. AJR Am J Roentgenol 217(1):157-163, 2021. e-Pub 2021. PMID: 33909469.
      33. Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, Aung PP, Gong J, Rodon J, Fu S, Stephen B, Roy-Chowdhuri S, Le H, Yang V, Zarifa A, Abdelsalam ME, Jhingran A, Javle M, Pant S, Carter B, Milton DR, Sun R, Karp DD, Koay EJ, Yang Y, Wistuba II, Hwu P, Meric-Bernstam F, Naing A. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. J Immunother Precis Oncol 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
      34. Kaseb AO, Kappadath SC, Lee SS, Raghav KP, Mohamed YI, Xiao L, Morris JS, Ohaji C, Avritscher R, Odisio BC, Kuban J, Abdelsalam ME, Chasen B, Elsayes KM, Elbanan M, Wolff RA, Yao JC, Mahvash A. A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by (90)Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. J Hepatocell Carcinoma 8:1129-1145, 2021. e-Pub 2021. PMID: 34527608.
      35. Bajomy AA, Abdelsalam ME. Ruptured hepatocellular carcinoma following transarterial hepatic chemoembolization. J Imaging Interv Radiol 4(5:4), 2021. e-Pub 2021.
      36. Bajomy AA, Abdelsalam M. Subclavian vein injury during placement of the right internal jugular dialysis catheter. Am J Interv Radiol 5:12, 2021. e-Pub 2021.
      37. Abdelsalam ME, Figueira A, Ensor J, Tam A, Avritscher R, Kaseb A, Gupta S. Survival impact of C-Arm cone-beam computed tomography on hepatocellular carcinoma patients undergoing chemoembolization. Am J Interv Radiol 5:9, 2021. e-Pub 2021.
      38. Thomas MA, Mahvash A, Abdelsalam M, Kaseb AO, Kappadath SC. Planning dosimetry for 90 Y radioembolization with glass microspheres: evaluating the fidelity of 99m Tc-MAA and partition model predictions. Med Phys 47(10):5333-5342, 2020. e-Pub 2020. PMID: 32790882.
      39. Abdelsalam ME, Kappadath SC, Mahvash A. Blood flow diversion using the microvascular plug to avoid non target delivery of radioactive microspheres. Radiol Case Rep 15(10):2015-2017, 2020. e-Pub 2020. PMID: 32874402.
      40. Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma 7:117-131, 2020. e-Pub 2020. PMID: 32984089.
      41. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
      42. Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma:3-55-61, 2016. e-Pub 2016.
      43. Tam AL, Melancon MP, Abdelsalam M, Figueira TA, Dixon K, McWatters A, Zhou M, Huang Q, Mawlawi O, Dunner K, Li C, Gupta S. Imaging intratumoral nanoparticle uptake after combining nanoembolization with various ablative therapies in hepatic VX2 rabbit tumors. J Biomed Nanotechnol 12(2):296-307, 2016. e-Pub 2016. PMID: 27305763.
      44. Abdelsalam ME, Mahvash A, Avritscher R, McRae SE, Odisio BC. Balloon-Assisted Flow Diversion and Selective Catheterization of Target Vessels for Hepatic Transarterial Embolization. J Vasc Interv Radiol 27(2):283-5, 2016. e-Pub 2016. PMID: 26830942.
      45. Eggers MD, McArthur MJ, Figueira TA, Abdelsalam ME, Dixon KP, Pageon LR, Wallace MJ, Huang SY. Pilot in vivo study of an absorbable polydioxanone vena cava filter. J Vasc Surg Venous Lymphat Disord 3(4):409-420, 2015. e-Pub 2015. PMID: 26992619.
      46. Tam AL, Ensor JE, Zvavanjanja RC, Philip A, Abdelsalam ME, Huang SY, Gupta S, Jones AK. JOURNAL CLUB: Standardizing CT-Guided Biopsy Procedures: Patient Dose and Image Noise. AJR Am J Roentgenol 205(4):W390-9, 2015. e-Pub 2015. PMID: 26397346.
      47. Zhao J, Vykoukal J, Abdelsalam M, Recio-Boiles A, Huang Q, Qiao Y, Singhana B, Wallace M, Avritscher R, Melancon MP. Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma. Nanotechnology 25(40):405101, 2014. e-Pub 2014. PMID: 25211057.
      48. Tam AL, Abdelsalam ME, Gagea M, Ensor JE, Moussa M, Ahmed M, Goldberg SN, Dixon K, McWatters A, Miller JJ, Srimathveeravalli G, Solomon SB, Avritscher R, Wallace MJ, Gupta S. Irreversible electroporation of the lumbar vertebrae in a porcine model: is there clinical-pathologic evidence of neural toxicity?. Radiology 272(3):709-19, 2014. e-Pub 2014. PMID: 24766034.
      49. Huang SY, Abdelsalam ME, Harmoush S, Ensor JE, Chetta JA, Hwang KP, Stafford RJ, Madoff DC, Avritscher R. Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. J Magn Reson Imaging 39(3):590-7, 2014. e-Pub 2014. PMID: 24532376.
      50. Avritscher R, Abdelsalam ME, Javadi S, Ensor J, Wallace MJ, Alt E, Madoff DC, Vykoukal JV. Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol 24(12):1871-8, 2013. e-Pub 2013. PMID: 24144538.
      51. Enriquez J, Javadi S, Murthy R, Ensor J Jr, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients. Acta Radiol 54(7):790-4, 2013. e-Pub 2013. PMID: 23535183.

      Invited Articles

      1. Abdelsalam ME, Ahrar K. Ablation of Small Renal Masses. Tech Vasc Interv Radiol 23(2):100674, 2020. e-Pub 2020. PMID: 32591194.
      2. Abdelsalam ME, Mahvash A, Madoff DC, Odisio BC, Kuban JK, Avritscher R, Murthy R. Radioembolization in colorectal metastases: a review. Dig Dis Interv 01(03):208-217, 2017. e-Pub 2017.

      Review Articles

      1. Awad A, Ahrar K, Stafford J, Abdelsalam ME. MR Imaging-Guided Cryoablation of Small Renal Masses. Magn Reson Imaging Clin N Am 33(4):735-741, 2025. e-Pub 2025. PMID: 42579738.
      2. Khavandi MM, Nezami N, Huang SY, Tam AL, Odisio BC, Mahvash A, Abdelsalam ME, Kuban JD, Sheth RA, Habibollahi P. Optimizing Care and Maintenance of Enteric Tubes: Insights into Percutaneous Radiologically Placed Gastrointestinal Luminal Tubes. Semin Intervent Radiol 42(1):48-56, 2025. e-Pub 2025. PMID: 40342385.
      3. Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma 3:55-61, 2016. e-Pub 2016. PMID: 27785450.

      Other Articles

      1. Williams U, VanMeter A, Lim J, Vacchani S, Sabir S, Abdelsalam M Radial nerve injury following renal radiofrequency ablation in the lateral decubitus position. Open Jrnl of Clinical & Medical Case Reports 2(7):1-6, 2017.

      Abstracts

      1. Khavandi MM, Gao M, Abdelsalam M, Avritscher R, Chen S, Yevich S, Sheth RA, Kuban JD, Habibollahi P. From Leak to Resolution: Outcomes After Intranodal Lymphangiography and Embolization for Chylous Leaks in Cancer Patients. SIR 2026 (Society of Interventional Radiology), 2026. e-Pub 2026.
      2. Khavandi MM, Awazi A, Shah KY, Abdelsalam ME, Nezami N, Avritscher R, Odisio BC, Lee SS, Kaseb A, Kuban JD, Kappadath S, Mahvash A, Habibollahi P. Outcomes of Resin Yttrium-90 Radioembolization with Advanced Dosimetry for Large HCC Tumors (>8 cm): A Retrospective Cohort. SIR 2026 (Society of Interventional Radiology), 2026. e-Pub 2026.
      3. Khavandi MM, Gao M, Shah K, Avritscher R, Abdelsalam M, Chen S, Yevich S, Sheth R, Kuban J, Habibollahi P. Intranodal Lymphangiography and Lymphatic Embolization for Spontaneous Chyle Leaks in Cancer Patients: A Single-Center Retrospective Experience. CIRSE 2025, 2025. e-Pub 2025.
      4. Khavandi MM, Metwalli Z, Lin E, Abdelsalam M, Kappadath C, Kuban J, Mahvash A, Habibollahi P. 3.Alterations of CT-Based Tumor-to-Normal Liver Ratio in Correlation to Tc-99m MAA Uptake with Pressure-Enabled Delivery. CIRSE 2025, 2025. e-Pub 2025.
      5. Khavandi M, Haddad A, Lendoire M, Acidi B, Chiang Y, Gupta S, Tam A, Odisio B, Mahvash A, Abdelsalam M, Lin E, Kuban J, Newhook T, Cao H, Tzeng C, Huang S, Vauthey J, Habibollahi P. Comparative Efficacy of Liver Venous Deprivation and Portal Vein Embolization in Enhancing Future Liver Remnant Hypertrophy for Extensive Colorectal Liver Metastases: A Propensity Score Matched Analysis. SIR 2025 (Society of Interventional Radiology), 2025. e-Pub 2025.
      6. Khavandi MM, Haddad A, Gupta S, Tam AL, Odisio BC, Mahvash A, Abdelsalam ME, Lin EY, D Tzeng CW, Tran Cao HS, Kuban JD, Huang SY, Vauthey J, Habibollahi P. Liver Venous Deprivation Versus Portal Vein Embolization For Patients With Extensive Colorectal Liver Metastases: Propensity Score Matched Analysis. Radiological Society of North America, 2024. e-Pub 2024.
      7. Awad A, Ahrar K, Kang F, Raymond R, D, Lu T, Karam J Matin S, Abdelsalam M. Long term outcomes of Cryoablation for solitary T1a Renal cell carcinoma. GEST (Global Embolization Symposium & Technologies) 2024 35(6):e50, 2024. e-Pub 2024.
      8. Celii F, Abdelsalam ME, Foss W, Awad A, Karam JA, S Matin SF, Ahrar K. Safety and Efficacy of Single-Session, Single-Position (Prone) Combined Trans-Radial Renal Embolization and Ablation Treatment of cT1 Renal Cell Carcinoma. GEST (Global Embolization Symposium & Technologies) 2024 35(6):e67, 2024. e-Pub 2024.
      9. Reed P, Ahrar K, Matin SF, Karam JA, Abdelsalam M. Thermal Ablation as a Salvage Treatment for Locally Recurrent RCC Following Surgery. GEST (Global Embolization Symposium & Technologies) 2024 35(6):e73, 2024. e-Pub 2024.
      10. Awad A, Ahrar K, Irwin D, Lu T, Karam J, Matin S, Abdelsalam M. Outcomes of Cryoablation for T1b Renal Tumors. SIR Annual Scientific Meeting (Society of Interventional Radiology ) 35(3):S105-S106, 2024. e-Pub 2024.
      11. Khavandi M, Lin E, Bande K, Mahvash A, Odisio B, Abdelsalam M, Kuban J, Tzeng C, Cao H, Vauthey J, Huang S, Habibollahi P. Enhanced Liver Hypertrophy and Future Liver Remnant Increase Through Liver Venous Deprivation Prior to Hepatectomy: A Single-Center Retrospective Experience. SIR 2024 (Society of Interventional Radiology), 2024. e-Pub 2024.
      12. Khavandi M, Lin E, Bande K, Mahvash A, Odisio B, Abdelsalam M, Kuban K, C Tzeng C, Tran Cao H, Vauthey J, Huang SH, Habibollahi P. Enhanced Liver Hypertrophy and Future Liver Remnant Increase Through Liver Venous Deprivation Prior to Hepatectomy 35(3):S9-S10, 2024. e-Pub 2024.
      13. Mahvash A, Habibollahi P, Abdelsalam M, Odisio B, Metwalli Z, Kappadath C. Safety and Efficacy of Y90 Resin Microsphere Treatment of Large Volume Primary and Secondary Liver Tumors Using Two SirSphere Parent Vials. CIRSE 2023, 2023. e-Pub 2023.
      14. Habibollahi P, Yevich S, Abdelsalam ME, Odisio B, Nezami N, Sheth R. Combination of Immunotherapy and Cryoablation for the Treatment of Adrenal Single-site Metastatic Disease Progression in Patients with Metastatic Melanoma. CIRSE 2023, 2023. e-Pub 2023.
      15. Mahvash A, Henry C, Lopez B, Abdelsalam M, Chasen B, Kuban J, Metwalli Z, Odisio B, Habibollahi P, Murthy R, Kaseb A, Kappadath C. Radioembolization for HCC patients with personalized Yttrium-90 dosimetry for curative intent (RAPY90D). Global Embolization Oncology Symposium Technologies 2023, 2023. e-Pub 2023.
      16. Abdelsalam M, Awad A, Lu T, Karam J, Matin S, Ahrar K. Effectiveness of Radiofrequency Ablation for Biopsy Proven T1a Renal Cell Carcinoma (RCC) Greater than or Equal to 3 cm. JVIR 34(3):S8, 2023. e-Pub 2023.
      17. Abdelsalam ME, Awad A, Baiomy A, Karam JA, Matin S, Ahrar K. Long-term Survival Outcome Radiofrequency Ablation of Biopsy Proven T1a Renal Cell Carcinoma (RCC). Cardiovasc Intervent Radiol 45(4):S239, 2022. e-Pub 2022.
      18. Abdelsalam ME, Mecci N, Award A, Lu T, Matin S, Karam JA, Ahrar K. The 10 years survival outcome of MRI guided cryoablation for biopsy proven T1a renal cell carcinoma (RCC). Cardiovasc Intervent Radiol 45(4):S842, 2022. e-Pub 2022.
      19. Mahvash A, Odisio B, Abdelsalam M, Kuban J, Metwalli Z, Chasen B, Kaseb A, Kappadath S. Radioembolization for HCC patients with personalized Yttrium-90 dosimetry for curative intent (RAPY90D) 33(6):S92, 2022. e-Pub 2022.
      20. Kappadath S, Henry C, Lopez B, Abdelsalam M, Chasen B, Kaseb A, Kuban J, Metwalli Z, Odisio B, Mahvash A. Radioembolization for HCC patients with personalized Yttrium-90 dosimetry for curative intent (RAPY90D): an interim analysis. Society of Nuclear Medicine and Molecular Imaging 2022 63(2), 2022. e-Pub 2022.
      21. Nguyen TT, Abdelsalam ME, Klimkowski S, Badawy M, Soliman M, Wong VK, Elsayes KM. Renal bleeding in cancer patient cross-sectional imaging and role of intervention in management. 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2021. e-Pub 2021.
      22. Abdelsalam ME, Mecci N, Kusin SB, Karam J, Matin SF, Wood CG, Ahrar K. MRI-guided cryoablation of denovo solitary pathologically-proven T1a renal tumors. Proceedings of the 46th Annual Meeting of the Society of Interventional Radiology, 2021. e-Pub 2021.
      23. Abdelsalam ME, Sabir SH, Hudspeth TN, Kusin SB, Matin SF. Efficacy of percutaneous image-guided thermal ablation for renal cell carcinoma following ipsilateral partial nephrectomy. Proceedings of the 45th Annual Meeting of the Society of Interventional Radiology, 2020. e-Pub 2020.
      24. Kappadath S, Tevateeti A, Long J, Abdelsalam ME, Avritscher R, Chasen B, Kuban J, Murthy R, Odisio B, Macapinlac H, Mahvash A. Survival outcomes for transarterial 90Y-radioembolization with glass microspheres in advanced hepatocellular carcinoma patients. J. Vasc. Interv. Radiol 31(3):S244-S245, 2020. e-Pub 2020.
      25. Gurusamy V, Odisio B, Kuban J, Abdelsalam ME, Avritscher R, Chasen B, Murthy R, Mahvash A. Temporary reversal of hepatoenteric collaterals during Y90 planning and treatment. J Vasc. Interv. Radiol 31(3):S245, 2020. e-Pub 2020.
      26. Abdelsalam ME, Hudspeth TN Sabir SH, Kusin SB, Matin SF, Wood CG, Karam J, Ahrar K. Oncologic effectiveness of image guided thermal ablation for recurrent renal cell carcinoma (RCC) after ipsilateral partial nephrectomy: Tertiary cancer center experience. Proceedings of the 2019 Meeting of the American Urological Association, 2019. e-Pub 2019.
      27. Donato Jr F, Ahrar K, Abdelsalam M, Tam A, Avritscher R, Sheth R, Sabir S. Combined transarterial renal embolization and percutaneous image-guided renal ablation for treatment of T1B and central renal cell carcinomas in patients with high surgical risk. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology 30(3):S151, 2019. e-Pub 2019.
      28. Abdelsalam M, Sabir SH, Leonards L, Kusin S, Wood C, Karam J, Matin S, Ahrar K. Radiofrequency ablation of pathologically proven T1a renal tumors: 16 years’ experience. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology, 2019. e-Pub 2019.
      29. Abdelsalam ME, Sabir S, Megahed A, Kattan A, Maaly A, Elsewafy M, Ahrar K. Magnetic resonance image guided renal biopsy: tertiary cancer center experience. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology 30(3):S222, 2019. e-Pub 2019.
      30. Mahvash A, Abdelsalam ME, Avritscher R, Dimayuga MB, Chasen B, Kuban JD, Le D, Patel M, Santiago G, Odisio BC, Murthy R, Kappadath SC. Feasibility of single session in-room Yttrium-90 radioembolization (RE) diagnostic angiography and treatment. Proceedings of the 44th Annual Meeting of the Society of Interventional Radiology, 2019. e-Pub 2019.
      31. Low JM, Abdelsalam ME, Odisio BC, Appleton-Figueira T, Abdel-Wahab R, Hassan M, Kaseb AO. Oncologic effectiveness of transarterial chemoembolization in local control of large hepatocellular carcinoma. J Clin Oncol 36(Number 15_suppl), 2018. e-Pub 2018.
      32. Abdelsalam ME, Sabir SH, Kusin SB, Matin SF, Wood CG, Karam JA, Ahrar K. Radiofrequency ablation of pathologically proven T1a renal tumors: 15 years follow up — a tertiary cancer center experience. J Clin Oncol 36(Number 15_suppl), 2018. e-Pub 2018.
      33. Hudspeth TN, Abdelsalam ME, Sabir SH, Kusin SB, Matin SF, Wood CG, Karam JA, Ahrar K. Minimally invasive image guided thermal ablation for recurrent renal cell carcinoma (RCC) after ipsilateral partial nephrectomy. J Clin Oncol 36(Number 15_suppl), 2018. e-Pub 2018.
      34. Abdelsalam ME, Sabir SH, Jusin SB, Karam J, Matin SF, Wood CG, Ahrar K. Long-term follow-up of image guided thermal ablation for pathologically proven T1a renal tumors: radiofrequency ablation or cryoablation. J Vasc Interv Radiol 29(4):S105, 2018. e-Pub 2018.
      35. Abdelsalam ME, Sabir SH, Kusin SB, Matin SF, Wood CG, Karam J, Ahrar K. Image guided thermal ablation for pathologically proven T1a renal cell carcinoma in the setting of other non-renal primary cancer: a tertiary cancer center experience. J Vasc Interv Radiol 28(2):S38-S39, 2017. e-Pub 2017.
      36. Abdelsalam ME, Sabir SH, Fellman B, Kusin SB, Matin SF, Wood CG, Karam J, Ahrar K. Overall survival after image guided thermal ablation of pathologically proven T1a RCC in cancer survivors. J Clin Oncol 34(Number 15_suppl), 2016. e-Pub 2016.
      37. Odisio BC, Figueira TA, Sabir SH, Wei W, Abdelsalam ME, Huang SY, Tam AL, Mahvash A, Gupta S, Wallace MJ, Vauthey JN, Kaseb AO. Large solitary hepatocellular carcinomas treated with transarterial chemoembolization: In which BCLC Stage patients should be allocated?. J Hepatol 64:S321-S322, 2016. e-Pub 2016.
      38. Abdelsalam ME, Sabir SH, Kusin SB, Matin SF, Wood CG, Karam JA, Ahrar K. Incidental renal tumors in cancer survivors: Minimally invasive management by image-guided thermal ablation. J Clin Oncol 34(Number 3_suppl), 2016. e-Pub 2016.
      39. Williams UU, Ruiz JR, Van Meter A, Abdelsalam ME, Wallace MJ. Radial nerve injury following renal ablation in the lateral position. Proceedings of the 68th Postgraduate Assembly in Anesthesiology, 2014. e-Pub 2014.
      40. Eggers M, Huang SY, Dixon K, Appleton Figueira T, Abdelsalam ME, Wallace MJ. In vivo analysis of polydioxanone for the development of absorbable vascular filters. J Vasc Interv Radiol 25(3):S87, 2014. e-Pub 2014.
      41. Baiomy A, Amir Habra M, Morani AC, Korivi BR, Abdelsalam ME, Elsayes KM. Cushing syndrome; pathogenesis, diagnostic work and spectrum of imaging findings with pathologic correlation and impact on clinical management. Proceedings of the Radiological Society of North America's 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
      42. Tam AL, Melancon MP, Ensor J, Pageon L, Abdelsalam, ME, Appleton-Figueria T, Dixon K, Miller JM, McWatters A, Li C, Gupta S. Nanoparticle distribution after treatment of rabbit VX2 hepatic tumor with nanoparticle embolization and irreversible electroporation (IRE) or radiofrequency ablation (RFA). Proceedings of the Radiological Society of North America's 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
      43. Zhao J, Bykoukal J, Abdelsalam ME, Recio-boiles A, Javadi S, j B, Wallace MF, Avritscher R, Melancon MP. Adipose-derived stem cells labeled with SPIO-coated hollow gold nanoshells as theranostic approach for liver injury. J Vasc Interv Radiol 24(4):S89-S90, 2013. e-Pub 2013.
      44. Avritscher R, Abdelsalam ME, Javadi S, Ensor J, Dixon K, Wallace MD Alt E, Vykoukal J. Percutaneous catheter-based portal application of adipose tissue derived mesenchymal stem cells (AD-MSCs) in a large animal model of liver cirrhosis. J Vasc Interv Radiol 24(4):S6-S7, 2013. e-Pub 2013.
      45. Abdelsalam ME, Gagea-lurascu M, Joseph E, Dixon K, McWatters A, Miller JM, Avritscher R, Gupta S, Wallace MJ, Tam AL. Irreversible electroporation (IRE) ablation of the lumbar vertebrae in a porcine model: A correlation of clinical, radiologic and pathologic findings. J Vasc Interv Radiol 24(4):S32, 2013. e-Pub 2013.
      46. Huang SY, Harmoush S, Abdelsalam ME, Ensor J, Dixon K, Hwang K, Avritscher R. Evaluation of liver fibrosis and hepatic venous pressure gradient with magnetic resonance elastography in a novel swine model of cirrhosis. Proceedings of the International Society for Magnetic Resonance in Medicine's 21st Annual Meeting & Exhibition, 2013. e-Pub 2013.
      47. Jones, AK, Sui D, Abdelsalam ME, Bassett RL JR, Wallace MJ. Complexity should be accounted for in dose assessment for transarterial chemoembolization. J Vasc Interv Radiol 24(4):S166, 2013. e-Pub 2013.
      48. Abdelsalam ME, Chetta J, Harmoush S, Joseph E, Baugh A, Dixon K, McWatters A, Wallace MJ, Tam AL, Avritscher R. Irreversible electroporation (IRE) in cirrhotic liver: Preliminary experience in a large animal model. J Vasc Interv Radiol 24(4):S46, 2013. e-Pub 2013.
      49. Abdelsalam ME, Chetta JA, Harmoush S, Ensor J, Javadi S, Dixon K McWatters A, Wallace MJ, Tam AL, Avritscher R. CT findings after irreversible electroporation ablation in porcine model: radiologic-pathologic correlation. J Vasc Interv Radiol 24(4):S161, 2013. e-Pub 2013.
      50. Youssef A, Salem U, Abdelsalam ME, Elwakeel M, Amini B. Imaging of cutaneous and subcutaneous nodules in oncology patient. Proceedings of the European Society of Radiology's 2013 European Congress of Radiology, 2013. e-Pub 2013.
      51. Jones AK, Abdelsalam ME, Wallace MJ. Impact of flat panel CT (PFCT) on hepatic chemoembolization procedures. Proceedings of the Radiological Society of North America's 98th Scientific Assembly and Annual Meeting, 2012. e-Pub 2012.
      52. Zvavanjanja R, Jones AK, Ensor J, Abdelsalam, ME, Huang SY, Gupta S, Tam AL. Standardization of computed tomographic (CT) technique used during biopsy procedures results in overall patient dose reduction regardless of biopsy site. Proceedings of the Radiological Society of North America's 98th Scientific Assembly and Annual Meeting, 2012. e-Pub 2012.
      53. Jones K, Ensor J, Zvavanjanja R, Pomares M, Abdelsalam ME, Harris K, Huang SY, Gupta S, Tam AL. Creation and implementation of a standard work for computed tomography (CT)-guided biopsy procedures. Proceedings of the Radiological Society of North America's 98th Scientific Assembly and Annual Meeting, 2012. e-Pub 2012.
      54. Abdelsalam ME, Gagea M, Dixon K, McWatters A, Miller J, Tam A. Irreversible electroporation (IRE) ablation of the lumbar vertebrae in a porcine model. Proceedings of the Society of Interventional Oncology's 4th Annual World Conference of Interventional Oncology, 2012. e-Pub 2012.
      55. Melancon MP, Vykoukal J, Abdelsalam ME, Zhao J, Hazle JD, Wallace MJ, Li C, Bankson J, Stafford RJ, Avritscher R. MR imaging for SPIO-labeled adipose-derived stem cells as a theranostic approach to management of liver injury. Proceedings of the International Society for Magnetic Resonance in Medicine's 20th Annual Meeting & Exhibition, 2012. e-Pub 2012.
      56. Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam M, Madoff D, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Proceedings of the Global Embolization Symposium and Technologies Meeting, 2012. e-Pub 2012.
      57. Speer ME, Abdelsalam ME, Chasen B, Murthy R, Mahvash A, Avritscher R. The retroportal artery and other less well-known hepatoenteric pathways: moving beyond GDA and right gastric embolization. J Vasc Interv Radiol 23(3):S151, 2012. e-Pub 2012.
      58. Abdelsalam ME, Joseph E JR, Tam A, Avritscher R, Gupta S, Wallace MJ. Impact on C-arm cone beam CT on subselective catheterization in patients undergoing chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 23(3):S14, 2012. e-Pub 2012.

      Book Chapters

      1. Saenz F, Khalili N, Khalili N, Mahvash A, Kuban JD, Abdelsalam ME. Interventional radiology (IR). In: Fundamentals of Diagnostic and Interventional Radiology. 1st Edition. Medblend Publishing, 220-230, 2025.
      2. Abdelsalam ME, Matin SF, Ahrar K. Ablation of Renal Cell Carcinoma in: Image-Guided Interventions. In: Elsevier Third Edition, 2020.
      3. Abdelsalam ME, Sheth R, Gupta S. Biopsies. In: Interventional Radiology: Fundamentals of Clinical Practice, Ed(s) BB Pua, AM Covey, DC Madoff. First. In: Interventional Radiology, 2019.
      4. Abdelsalam ME, Kobayahsi K, Avritscher R, Gupta S, Tam AL. Intraarterial procedures for the musculoskeletal system. In: Clinical Interventional Oncology. 1st. Elsevier, 342, 2014.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 01, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top